How to Help Your Patients Find Suprax in Stock: A Provider's Guide

Cefixime (Suprax) occupies an important niche in outpatient infectious disease management. It's FDA-approved for uncomplicated UTIs, otitis media, pharyngitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea. But its limited manufacturer base and lower prescribing volume relative to first-line antibiotics mean it isn't always sitting on pharmacy shelves. This guide outlines what's driving the availability gap and provides actionable steps you can integrate into your prescribing workflow.

Understanding the Access Problem

As of early 2026, cefixime is not on the FDA or ASHP drug shortage lists. The issue is not a true shortage but rather a practical access problem driven by:

• Limited manufacturers: Generic cefixime is produced primarily by Lupin Pharmaceuticals and Aurobindo Pharma. A small manufacturer base means any production disruption has outsized impact.
• On-demand stocking at chains: Chain pharmacies order cefixime on demand rather than keeping it stocked, leading to 1–2 day delays even when no supply disruption exists.
• API sourcing risk: Active pharmaceutical ingredients sourced from overseas create vulnerability to international supply disruptions.

Step 1: Verify Stock Before the Patient Leaves Your Office

The single most impactful workflow change you can make is verifying pharmacy availability before the patient leaves your clinic. Use medfinder for Providers at medfinder.com/providers to check real-time pharmacy stock in your patient's area. Enter the medication, dosage, and the patient's zip code to see which pharmacies currently have cefixime in stock — including the specific formulation (capsule, chewable tablet, or suspension).

This takes 60 seconds and can prevent a frustrating hour of phone calls for your patient — and a follow-up call to your office when they can't fill the prescription.

Step 2: Direct Patients to the Right Pharmacy Type

Not all pharmacies are equally likely to have cefixime in stock. Advise patients accordingly:

• Recommend independent pharmacies first. They have more wholesaler relationships and more agile ordering practices. Most can order cefixime with next-business-day delivery if not immediately in stock.
• Chain pharmacy: If the patient insists on a chain, ask them to call ahead before driving to the pharmacy.
• Hospital outpatient pharmacy: If your practice is affiliated with a hospital system, these pharmacies often have more reliable supply through institutional distribution channels.

Step 3: Formulation-Specific Prescribing

Prescribing the correct formulation upfront avoids refill delays. Key clinical notes:

• Otitis media: Prescribe the chewable tablet or oral suspension, not the 400 mg tablet or capsule. The chewable/suspension achieves higher serum concentrations and was used in clinical otitis media trials.
• Adult infections: The 400 mg tablet and 400 mg capsule are interchangeable for adults. If one formulation is unavailable, the prescription can be updated to the other without a clinical concern.
• Oral suspension concentrations: Available in three concentrations (100 mg/5 mL, 200 mg/5 mL, 500 mg/5 mL). Always specify concentration when prescribing to avoid dispensing errors.

Step 4: Have a Pre-Specified Alternative Ready

When prescribing cefixime, build a contingency alternative into your EHR note or after-visit summary. This allows your staff to quickly send an alternative prescription if the patient calls back unable to fill cefixime — without requiring you to re-evaluate the case from scratch.

Suggested contingency alternatives by indication:

• UTI → Cefpodoxime 100 mg BID x 7d or Nitrofurantoin 100 mg BID x 5d
• Otitis media → Amoxicillin 80–90 mg/kg/day x 10d (or 5–7d for mild cases in older children)
• Pharyngitis → Penicillin V 500 mg BID-TID x 10d or Amoxicillin 500 mg BID x 10d
• Bronchitis exacerbation → Azithromycin 500 mg day 1, then 250 mg x 4d; or Doxycycline 100 mg BID x 5–7d
• Gonorrhea → Ceftriaxone 500 mg IM single dose (CDC preferred first-line — recommend this over oral cefixime for all gonorrhea cases)

Step 5: Address Cost Barriers Proactively

Cost-related non-fill is common with brand Suprax ($150–$252+ cash). Prescribe generic cefixime by default and advise patients to use a free discount card from GoodRx or SingleCare, which can bring the cost to as low as $14–$20. No manufacturer copay card is currently available for generic cefixime, but Prescription Hope offers brand Suprax access at $70/month for qualifying patients.

For a dedicated cost guide to share with patients, see: How to Help Your Patients Save Money on Suprax: A Provider's Guide to Savings Programs